| Typicality: | 0.639 |
| Saliency: | 0.606 |
| by colleagues | 6 | other |
| trial → be included in → the meta-analysis | 75 |
| trial → be included in → this meta-analysis | 22 |
| trial → be included in → our meta-analysis | 7 |
| trial → be included in → the meta-analyses | 6 |
| trial → be included in → meta-analysis | 5 |
| trial → be included in → meta-analyses | 5 |
| trial → be included in → a meta-analysis | 5 |
| trial → be included in → current meta-analysis | 3 |
| trial → included in → the meta-analysis | 3 |
| negative | neutral | positive |
| 0.188 | 0.729 | 0.083 |
| Raw frequency | 131 |
| Normalized frequency | 0.606 |
| Modifier score | 0.900 |
| Perplexity | 51.510 |